Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Geissler

Showing results (21-30 of 449) with videos related to

Pageof 45
Sort By:
Acta Medica Austriaca. Supplement|March 23, 2001
[Cytokine combinations for in vivo and ex vivo expansion of hematopoietic progenitor cells]K Geissler, T Wagner
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2025
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: a breakthrough to a new horizon?Edward K Geissler, Birgit Sawitzki
Blood|July 23, 2011
Innovative blood vessels bring new lifeEdward K Geissler, Peter Angele
Transplantation Research|February 2, 2013
Open new possibilities in Transplantation ResearchEdward K Geissler, Alan Jardine
Radiologic Technology|November 5, 1999
Tic-tac-toeK Geissler, D E Collins
Transplantation Proceedings|February 1, 1997
Effect of portal vein injection of allo-MHC-transfected hepatocytes on immunity prior to organ transplantationC Graeb, E K Geissler
Transplantation|April 5, 2011
Late deaths: what can we learn?Edward K Geissler, Hans J Schlitt
Kidney International|November 19, 2015
The Authors ReplyJames A Hutchinson, Edward K Geissler
Kidney International|March 5, 2015
Now or never? The case for cell-based immunosuppression in kidney transplantationJames A Hutchinson, Edward K Geissler
Acta Medica Austriaca. Supplement|January 1, 2003
[Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)]K Geissler, Hermine Agis, Verena Sagaster
Pageof 45

Showing results (21-30 of 449) with videos related to

Sort By:
Pageof 45
Acta Medica Austriaca. Supplement|March 23, 2001
[Cytokine combinations for in vivo and ex vivo expansion of hematopoietic progenitor cells]K Geissler, T Wagner
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2025
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: a breakthrough to a new horizon?Edward K Geissler, Birgit Sawitzki
Blood|July 23, 2011
Innovative blood vessels bring new lifeEdward K Geissler, Peter Angele
Transplantation Research|February 2, 2013
Open new possibilities in Transplantation ResearchEdward K Geissler, Alan Jardine
Radiologic Technology|November 5, 1999
Tic-tac-toeK Geissler, D E Collins
Transplantation Proceedings|February 1, 1997
Effect of portal vein injection of allo-MHC-transfected hepatocytes on immunity prior to organ transplantationC Graeb, E K Geissler
Transplantation|April 5, 2011
Late deaths: what can we learn?Edward K Geissler, Hans J Schlitt
Kidney International|November 19, 2015
The Authors ReplyJames A Hutchinson, Edward K Geissler
Kidney International|March 5, 2015
Now or never? The case for cell-based immunosuppression in kidney transplantationJames A Hutchinson, Edward K Geissler
Acta Medica Austriaca. Supplement|January 1, 2003
[Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)]K Geissler, Hermine Agis, Verena Sagaster
Pageof 45